Ling Di Yin
Johns Hopkins University
Internal medicineUrologyOncologyPathologicalChemotherapyHepatectomyNeoadjuvant therapyPancreatectomyMetastasectomyLiquid biopsyPancreatic cancerBlood lossHazard modelingMedicine
1Publications
0Citations
Publications 2
Newest
#1Alex B. Blair (Johns Hopkins University)H-Index: 17
#2Ling Di Yin (JHUSOM: Johns Hopkins University School of Medicine)
Last. Jin He (Johns Hopkins University)H-Index: 40
view all 13 authors...
OBJECTIVE: The aim of this study was to characterize the patterns and treatment of disease recurrence in patients achieving a pathological complete response (pCR) following neoadjuvant chemoradiation for advanced pancreatic ductal adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA: A pCR is an independent predictor for improved survival in PDAC. However, disease recurrence is still observed in these patients. METHODS: Patients with advanced PDAC who were treated with neoadjuvant therapy and had a...
6 CitationsSource
Background Radical antegrade modular pancreatosplenectomy (RAMPS) has been adopted by some surgeons in the treatment of left-sided pancreatic cancer (PDAC). Low disease incidence and heterogenous disease biology make robust prospective comparison of RAMPS and standard distal pancreatosplenectomy (DPS) difficult. Methods Consecutive cases of chemo-naive patients undergoing open RAMPS and DPS for PDAC between 2010-2017 at two international high-volume pancreatectomy centers were compared. Cox prop...
1 CitationsSource